Pharmacology of antibiotic agents
Roger Brüggemann's and Nynke Jager's research group investigates the pharmacokinetics and dynamics of antimicrobial agents. Research ranges from in vitro experiments to clinical trials in special patient populations. The main aim is to define the optimal dose for each individual patient.
Pharmacology of anti-tuberculosis drugs
Rob Aarnoutse's research group investigates the pharmacology of existing and new drugs for tuberculosis, using a translational approach that extends from molecular pharmacology to clinical pharmacology studies and to clinical trials, supported by advanced laboratory and modeling techniques.
Pharmacology of antiviral drugs (HIV and HCV)
David Burger's group investigates the pharmacology of antiviral drugs for the treatment of HIV and hepatitis C in special patient population such as pregnant women, children and hepatically impaired patients. We also study drug-drug interactions and the impact on exposure of new drug-formulations.